Company / Goodwill
Revolution Medicines, Inc. Goodwill History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$14.6M
FY2025
5-year range
$14.6M / $14.6M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#59 of 75
Health Care
What the data says
Revolution Medicines, Inc.'s goodwill of $15M is lower than 79% of companies in the Health Care sector (FY2025). Goodwill remained relatively stable over the past 7 years, with values between $15M and $15M.
Based on SEC 10-K filings.
$15M in FY2025 with a 5-year CAGR of +0.0%.
Remained stable around $15M over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +0.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 75This company $14.6M Sector average $4.0B
▼
-99.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.0%, indicating consistent growth.
- In FY2025, goodwill increased 0.0% year-over-year.
- Ranks #59 out of 75 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.6M | +0.0% |
| FY2024 | $14.6M | +0.0% |
| FY2023 | $14.6M | +0.0% |
| FY2022 | $14.6M | +0.0% |
| FY2021 | $14.6M | +0.0% |
| FY2020 | $14.6M | +0.0% |
| FY2019 | $14.6M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026